M&A TRANSACTION · 2018
Xstrahl acquired by Risk Capital Partners
$25.0M· 9.6x EBITDA· 1.90x revenue
Target
Xstrahl
Acquirer
Risk Capital Partners
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
$13.5M
EBITDA
$2.6M
Deal Value
$25.0M
EV/EBITDA
9.6x
Context
This $25.0M acquisition of Xstrahl by Risk Capital Partners sits in the medical devices sub-vertical. The 9.6x EBITDA multiple paid in 2018 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Risk Capital Partners is acquiring as a private equity buyer; see how PE acquirers typically price medical devices businesses on our Medical Devices PE buyer-pool page.
Source
Data sourced from Press releases and press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Xstrahl acquisition.